Advertisement

Psychopharmacology

, Volume 64, Issue 3, pp 255–260 | Cite as

Maturational changes related to dopamine in the effects of d-amphetamine, cocaine, nicotine, and strychnine on seizure susceptibility

  • Charles A. Greer
  • Herbert P. Alpern
Original Investigations

Abstract

The effects of four neural excitants (d-amphetamine, cocaine, nicotine, and strychnine) on myoclonic and clonic seizure susceptibility were investigated in two age groups (30 and 120 days) of short-sleep mice. Amphetamine and cocaine decreased susceptibility to myoclonus in young mice and increased susceptibility in mature mice. These effects were attenuated by pretreatment with haloperidol, indicating mediation by a dopaminergic system. Amphetamine did not alter clonic susceptibility in either age group of mice, whereas cocaine affected clonic susceptibility and myoclonus. These effects were not attenuated by haloperidol, indicating mediation by systems other than dopamine. Nicotine decreased susceptibility to myoclonus and increased susceptibility to clonus, whereas strychnine increased susceptibility to both types of seizure. Haloperidol, however, failed to alter any of these effects. These results are consistent with our previous work which suggests that a dopaminergic mechanism in these mice undergoes marked developmental changes between 30 and 120 days of age.

Key words

d-Amphetamine Cocaine Nicotine Strychnine Seizure susceptibility Dopamine Development 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adler, M. W.: Lowered thresholds to flurothyl seizures after lateral geniculate lesions in rats. Int. J. Neuropharmacol. 8, 393–398 (1969)Google Scholar
  2. Alpern, H. P., Greer, C. A.: A dopaminergic basis for the effects of amphetamine on a mouse preadolescent hyperkinetic model. Life Sci. 21, 93–98 (1977)Google Scholar
  3. Alpern, H. P., Greer, C. A., Stripling, J., Collins, A., Olson, R.: Methaqualone: Tolerance and physical dependence in mice. Psychopharmacologia 44, 303–305 (1975)Google Scholar
  4. Alpern, H. P., Kimble, D.: Retrograde amnesic effects of diethyl ether and bis (trifluorethyl) ether. J. Comp. Physiol. Psychol. 63, 168–171 1967)Google Scholar
  5. Banerjee, U., Lin, G. S.: On the mechanism of central action of amphetamine: The role of catecholamines. Neuropharmacology 12, 917–931 (1973)Google Scholar
  6. Bhagat, B.: Effects of chronic administration of nicotine on storage and synthesis of noradrenaline in rat brain. Br. J. Pharmacol. 38, 86–92 (1970)Google Scholar
  7. Bhagat, B., Kramer, S. Z., Seifter, J.: The effects of nicotine and other drugs on the release of injected 3H-norepinephrine and on endogenous norepinephrine levels in the rat brain. Eur. J. Pharmacol. 2, 234–235 (1967)Google Scholar
  8. Campbell, B., Randall, P.: Paradoxical effects of amphetamine on behavioural arousal in neonatal and adult rats: A possible animal model of the calming effect of amphetamine on hyperkinetic children. In: Aberrant development in infancy, N. Ellis, ed., pp. 105–113 Hillsdale: Earlbaum 1975Google Scholar
  9. Campbell, B., Randall, P.: Paradoxical effects of amphetamine on preweanling and postweanling rats. Science 195, 888–891 (1977)Google Scholar
  10. Church, A., Fuller, J.: Motor responses to acute alcohol administration in mice selected for differential alcohol-induced sleep-time. Sixth Annual Behavior Genetics Association Meeting, 1976 (Abstract)Google Scholar
  11. Cools, A., Boudier, H., Van Rossum, J.: Dopamine receptors: Selective agonists and antagonists of functionally distinct types within feline brain. Eur. J. Pharmacol. 37, 283–293 (1976)Google Scholar
  12. Cools, A., Van Rossum, J.: Excitation-mediating and inhibition-mediating dopamine receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, function and clinical data. Psychopharmacologia 45, 243–254 (1976)Google Scholar
  13. Coyle, J., Molliver, M.: Major innervation of newborn rat cortex by monoaminergic neurons. Science 196, 444–447 (1977)Google Scholar
  14. Curtis, D. R.: Pharmacology and neurochemistry of mammalian central inhibitory processes. In: Structure and function of inhibitory neuronal mechanisms. C. von Euler, S. Skoglund, U. Soderberg, eds., pp. 429–456. Oxford: Pergamon 1968Google Scholar
  15. Dadkar, N. K., Dohadwalla, A. N., Bhattacharya, B. K.: Possible role of dopamine in central effects of cocaine as measured by apomorphine gnawing test in mice. Psychopharmacology 52, 115–117 (1977)Google Scholar
  16. Faber, D. S., Klee, M. R.: Strychnine interactions with acetylcholine, dopamine and serotonin receptors in Aplysia neurons. Brain Res. 65, 109–126 (1974)Google Scholar
  17. Fuxe, K., Agnati, L., Hokfelt, T., Jonsson, G., Lidbrink, P., Ljungdahl, A., Lofstrom, A., Ungerstedt, U.: The effect of dopamine receptor stimulating and blocking agents on the activity of super-sensitive dopamine receptors and on the amine turnover in various dopamine nerve terminal systems in the rat brain. J. Pharmacol. 6, 117–129 (1975)Google Scholar
  18. Galambos, E., Pfeifer, A. K., György, L., Molnár, J.: Study on the excitation induced by amphetamine, cocaine and α-methyltryptamine. Psychopharmacologia 11, 122–129 (1967)Google Scholar
  19. Greer, C. A., Alpern, H. P.: Mediation of myoclonic seizures by dopamine and clonic seizures by acetylcholine and GABA. Life Sci. 21, 385–392 (1977)Google Scholar
  20. Greer, C. A., Alpern, H. P.: Differential neurohumoral modulation of myoclonic and clonic seizures. Arch. Int. Pharmacol. Ther. 236, 74–85 (1978)Google Scholar
  21. Greer, C. A., Alpern, H. P.: Paradoxical effects of d-amphetamine upon seizure susceptibility: An ontogenetic investigation of dopaminergic modulation in two selectively bred lines of mice. Dev. Psychobiol., in press (1979)Google Scholar
  22. Greer, C. A., Alpern, H. P., Collins, A.: Increased sensitivity to flurothyl as a measure of physical dependence following morphine, phenobarbital, and ethanol treatment. Life Sci. 18, 1375–1382 (1976)Google Scholar
  23. Groves, P., Wilson, C., Young, S., Rebec, G.: Self-inhibition by dopaminergic neurons. Science 190, 522–529 (1975)Google Scholar
  24. Hall, G. H., Turner, D. M.: Effects of nicotine on the release of 3H-norepinephrine from the hypothalamus. Biochem. Pharmacol. 21, 1829–1838 (1972)Google Scholar
  25. Heston, W., Erwin, G.: A comparison of the effects of alcohol on mice selectively bred for differences in ethanol sleep-time. Life Sci. 14, 365–370 (1974)Google Scholar
  26. McClearn, G., Kakihana, R.: Selective breeding for ethanol sensitivity in mice. Behav. Genet. 3, 409 (1973)Google Scholar
  27. Moore, K. E., Thornburg, J. E.: Importance of brain dopamine for the stimulant actions of amphetamine. In: Frontiers in catecholamine research, E. Usdin, S. H. Snyder, eds., pp. 1031–1034. Oxford: Pergamon 1973Google Scholar
  28. Nose, T., Takemoto, H.: The effect of penfluridol and some psychotropic drugs on monoamine metabolism in central nervous system. Eur. J. Pharmacol. 31, 351–359 (1975)Google Scholar
  29. Rosecrans, J. A.: Effects of nicotine on brain area 5-hydroxytryptamine function in male and female rats separated for differences of activity. Eur. J. Pharmacol. 16, 123–127 (1971)Google Scholar
  30. Ross, S. B., Renyi, A. L.: Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. Eur. J. Pharmacol. 2, 181–186 (1967)Google Scholar
  31. Smith, C. B.: Effects of d-amphetamine upon brain amine content and locomotor activity of mice. J. Pharmacol. Exp. Ther. 147, 96–102 (1965)Google Scholar
  32. Starke, K., Taube, H., Borowski, E.: Presynaptic receptor systems in catecholaminergic transmission. Biochem. Pharmacol. 26, 259–268 (1977a)Google Scholar
  33. Starke, K., Taube, H., Borowski, E.: Pre- and postsynaptic receptors in catecholaminergic transmission. Arch. Pharmacol. 297, 43–44 (1977b)Google Scholar
  34. Stripling, J. S., Ellinwood, E.: Cocaine: Physiological and behavioral effects of acute and chronic administration. In: Cocaine: Chemical, biological, clinical, social, and treatment aspects, J. Mule, ed., pp. 167–185. West Palm Beach: CRC Press 1976Google Scholar
  35. Strombom, U.: On the functional role of pre- and postsynaptic catecholamine receptors in brain. Acta Physiol. Scand. (Suppl.) 431 (1975)Google Scholar
  36. Strombom, U.: Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine. J. Neurotrans. 40, 191–194 (1977)Google Scholar
  37. Thornburg, J. E., Moore, K. E.: The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs. Neuropharmacology 12, 853–866 (1973)Google Scholar
  38. Van Rossum, J. M., Van der Schoot, J. B., Hurkmans, J. A. Th. M.: Mechanisms of action of cocaine and amphetamine in the brain. Experientia 18, 229–231 (1962)Google Scholar
  39. Webb, O., Russell, P.: Diurnal chemoconvulsive response and central inhibition. Arch. Int. Pharmacodyn. Ther. 150, 177–185 (1966)Google Scholar
  40. Winer, B.: Statistical principles in experimental design. New York: McGraw-Hill 1971Google Scholar
  41. Wolf, H. H., Rollins, D. E., Rowland, C. R., Reigle, T. G.: The importance of endogenous catecholamines in the activity of some CNS stimulants. Int. J. Neuropharmacol. 8, 319–328 (1969)Google Scholar
  42. Zetler, G.: Drug-induced catalepsy as influenced by convulsant and anticonvulsant drugs. Neuropharmacology 12, 741–749 (1973)Google Scholar
  43. Zetler, G., Thorner, R.: Drug-induced catelepsy as influenced by psychostimulants, apomorphine, l-dopa, and yohimbine. Pharmacology 10, 238–251 (1973)Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • Charles A. Greer
    • 1
    • 2
  • Herbert P. Alpern
    • 1
    • 2
  1. 1.Department of PsychologyUniversity of ColoradoBoulderU.S.A.
  2. 2.Institute for Behavioral GeneticsUniversity of ColoradoBoulderU.S.A.

Personalised recommendations